Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
BioMarin Pharmaceutical Inc. (BMRN) had Return on Investments of -0.46% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$776.13M |
|
$-30.74M |
|
$140.09M |
|
$636.05M |
|
$822.83M |
|
$-46.69M |
|
$20.37M |
|
$-26.32M |
|
$-26.32M |
|
$-30.74M |
|
$-30.74M |
|
$-30.74M |
|
$-30.74M |
|
$-46.69M |
|
$-29.18M |
|
192.03M |
|
192.03M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$3.85B |
|
$1.04B |
|
$3.76B |
|
$7.61B |
|
$798.44M |
|
$596.66M |
|
$759.72M |
|
$1.56B |
|
$6.06B |
|
$5.63B |
|
$6.06B |
|
192.10M |
|
| Cash Flow Statement Financials | |
$728.35M |
|
$-371.79M |
|
$-45.55M |
|
$942.84M |
|
$1.25B |
|
$307.27M |
|
$134.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.83 |
|
-- |
|
-- |
|
0.09 |
|
0.10 |
|
81.95% |
|
-6.02% |
|
-6.02% |
|
-- |
|
-3.39% |
|
-3.96% |
|
$666.03M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.10 |
|
0.98 |
|
91.64 |
|
-0.51% |
|
-0.55% |
|
-0.40% |
|
|
Return on Investments |
-0.46% |
$31.53 |
|
$3.47 |
|
$3.79 |
|